Person: DAŞKAYA, HAYRETTİN
10 results
Search Results
Now showing 1 - 10 of 10
Publication Open Access Use of the gastro-laryngeal tube in endoscopic retrograde cholangiopancreatography cases under sedation/analgesia(2016-05-01) Daskaya, HAYRETTİN; UYSAL, HARUN; Ciftci, Taner; BAYSAL, Birol; IDIN, Kadir; Karaaslan, KAZIM; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; KARAASLAN, KAZıMBackground/Aims: In this study, we aimed to analyze the effects of Gastro-Laryngeal Tube (GLT) use on intraoperative and postoperative hemodynamic parameters, comfort of the procedure, and patients’ satisfaction in endoscopic retrograde cholangiopancreatography (ERCP). Materials and Methods: A total of 80 patients between the ages of 20 and 75 years who were scheduled for elective ERCP were enrolled. The patients were randomly assigned to two groups: groups N and G. Those in group N underwent the procedure with sedation without any airway instruments and those in group G underwent procedure after sedation and airway management with GLT. Intraoperative and postoperative vital signs as well as the satisfaction of the patients were recorded. Results: The duration to esophageal visualization was found to be significantly higher in group N (16 s) than in group G (7 s) (p=0.001). The mean Visual Analogue Scale for Pain (VAS) was significantly higher in group G (1.85) than in group N (0.45) (p=0.016). Group G had higher endoscopist satisfaction scores than group N. The incidence of desaturation during ERCP was significantly higher in group N (60%) than in group G (0%) (p=0.000). Conclusion: In conclusion, ERCP should be performed under optimal conditions to avoid the occurrence of unwanted complications, such as aspiration-related disorders. Therefore, according to the structural properties of GLT, sedation anesthesia application with GLT in ERCP will be safer, more comfortable, and more effective.Publication Metadata only Comparison of LMA® Gastro™ airway and gastrolaryngeal tube in endoscopic retrograde cholangiopancreatography: a prospective randomized observational trial(2021-05-13T00:00:00Z) Uysal, Harun; Senturk, HAKAN; Calim, Muhittin; Daskaya, Hayrettin; Guney, Ibrahim A; Karaaslan, Kazim; UYSAL, HARUN; ŞENTÜRK, HAKAN; DAŞKAYA, HAYRETTİNBackground: New generation airway devices with different designs have been developed as an alternative to endotracheal intubation in order to avoid adverse events associated with sedation in endoscopic procedures and to provide patent airway. We aimed to compare two supraglottic airway devices (SGADs), the LMA® Gastro™ airway and gastrolaryngeal tube (GLT), in terms of airway efficiency, performance during procedure and adverse events in endoscopic retrograde cholangiopancreatography (ERCP). Methods: A hundred-three ERCP patients without high risk of aspiration were included. Patients were randomly allocated to the LMA Gastro and GLT groups. The primary study outcomes were the comparison of the two SGADs in terms of oropharyngeal leak pressure (OLP). Secondary study outcome was SGADs-related adverse events. Results: Procedures were completed with SGADs in fifty patients in each group. The rate of successful insertion at first attempt was 72% in GLT and 96% in LMA Gastro (P=0.004). The mean OLP of LMA Gastro Group (31.8 cmH2O) was significantly higher than that of the GLT Group (26.5 cmH2O), (P=0.0001). However, endoscopists' satisfaction was higher in GLT (P=0.0001). Mucosal damage and sore throat were lower in LMA Gastro Group. Conclusions: LMA® Gastro™ had a higher OLP than GLT. However, GLT was better for endoscopist satisfaction, as it provides more satisfying maneuverability. As to secondary outcome advers events were lower in LMA® Gastro™. The lower complication rates associated with the device and providing a more patent airway also highlighted the apparent clinical efficacy of LMA® Gastro™ than GLT, in ERCP.Publication Metadata only The effect of gender on acute kidney injury developing in the intensive care unit.(2019-07-01T00:00:00Z) Güzel, C; Yeşiltaş, S; Daşkaya, H; Sümer, I; Türkay, M; YEŞİLTAŞ, SERDAR; DAŞKAYA, HAYRETTİN; UYSAL, HARUNPublication Metadata only Endoskopik ultrasonografi yapılan olgularda propofole ketamin veya fentanil ilavesinin sedo-analjezi kalitesi üzerine etkileri(2019-09-01T00:00:00Z) Daşkaya, Hayrettin; Uysal, Harun; Yılmaz İnal, Ferda; Esen, Asım; Karaaslan, Kazım; DAŞKAYA, HAYRETTİN; UYSAL, HARUNPublication Open Access Usefulness of oxidative stress marker evaluation at admission to the intensive care unit in patients with COVID-19(2021-07-01T00:00:00Z) Daşkaya, Hayrettin; Yılmaz, Sinan; Uysal, Harun; Sümbül, Bilge; Karaaslan, Kazım; DAŞKAYA, HAYRETTİN; YILMAZ, SİNAN; UYSAL, HARUN; ÇALIM, MUHITTIN; SÜMBÜL, BİLGE; YURTSEVER, İSMAİL; KARAASLAN, KAZıMObjective:Two critical processes in the coronavirus disease 2019 (COVID-19) pandemic involve assessing patients- intensive care needs and predicting disease progression during patients- intensive care unit (ICU) stay. We aimed to evaluate oxidative stress marker status at ICU admission and ICU discharge status in patients with COVID-19.Methods:We included patients in a tertiary referral center ICU during June-December 2020. Scores of Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA), and clinical severity, radiologic scores, and healthy discharge status were noted. We collected peripheral blood samples at ICU admission to evaluate total antioxidants, total oxidants, catalase, and myeloperoxidase levels.Results:Thirty-one (24 male, 7 female) patients were included. At ICU admission, patients- mean APACHE II score at ICU admission was 17.61 ± 8.9; the mean SOFA score was 6.29 ± 3.16. There was no significant relationship between clinical severity and oxidative stress (OS) markers nor between radiological imaging and COVID-19 data classification and OS levels. Differences in OS levels between patients with healthy and exitus discharge status were not significant.Conclusions:We found no significant relationship between oxidative stress marker status in patients with COVID-19 at ICU admission and patients- ICU discharge status.Publication Metadata only Endoskopik ultrasonografi yapılan olgularda propofole ketamin veya fentanil ilavesinin sedo-analjezi kalitesi üzerine etkileri(2019-08-01T00:00:00Z) Daşkaya, Hayrettin; Uysal, Harun; Yılmaz İnal, Ferda; Esen, Asım; Karaaslan, Kazim; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; ESEN, ASIM; KARAASLAN, KAZıMPublication Metadata only Gastro-laryngeal tube usage in ERCP sedo-analgesia cases(2014-06-02T00:00:00Z) Uysal, Harun; DAŞKAYA, HAYRETTİN; ÇİFTCİ, TANER; Baysal, Birol; İDİN, KADİR; KARAASLAN, KAZİM; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; KARAASLAN, KAZıMPublication Metadata only Utility of the gastro-laryngeal tube during transesophageal echocardiography: A prospective randomized clinical trial.(2022-12-16) Calim M.; Uysal H.; Kahraman Ay N.; Karaaslan K.; Daskaya H.; ÇALIM, MUHITTIN; UYSAL, HARUN; DAŞKAYA, HAYRETTİNPublication Metadata only Impact of the additive ketamine or fentanyl on quality ofsedation in endoscopic ultrasonography with propofol(2016-05-30T00:00:00Z) Uysal, Harun; DAŞKAYA, HAYRETTİN; YILMAZ İNAL, FERDA; ESEN, ASIM; KARAASLAN, KAZİM; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; ESEN, ASIM; KARAASLAN, KAZıMPublication Open Access The Effect of Exogenous Human Albumin Administration on Acute Kidney Injury Development in Hypoalbuminemic Patients in the Intensive Care Unit(2022-04-01T00:00:00Z) Yeşiltaş, Serdar; Güzel, Cumali; Sümer, İsmail; Uysal, Harun; Daşkaya, Hayrettin; Türkay, Meltem; Karaaslan, Kazım; YEŞİLTAŞ, SERDAR; SÜMER, İSMAİL; UYSAL, HARUN; DAŞKAYA, HAYRETTİN; KARAASLAN, KAZıMObjective: Hypoalbuminemia is an independent risk factor for acute kidney injury (AKI) and mortality. The primary aim of our study was to investigate the effect of exogenous human albumin (EHA) administration on hypoalbuminemic patients in the intensive care unit (ICU) regarding the development of AKI. Our secondary aim was to compare the ICU admission duration and mortality rates of these patients. Methods: After receiving ethics committee approval, the researchers retrospectively screened database for 5,989 patients admitted to the adult ICU from 01.01.2014 to 01.06.2018. The demographic data, serum albumin and creatinine levels, ICU admission duration and mortality rates of patients were recorded. Stage 2-3 AKI was accepted based on the AKI network criteria, while hypoalbuminemia was accepted as serum albumin values below 3.5 g/dL. Patients not given EHA were assigned to group none human albumin (Group NHA), while patients given EHA were assigned to group human albumin (Group HA). The rate of AKI development, duration of stay in ICU and mortality rates were compared between the groups. Results: The mean age, AKI development rate, mortality rate and ICU admission duration in Group HA were statistically significantly higher than in Group NHA (p=0.0001, p=0.0001, p=0.0001, p=0.0001). There was no difference in terms of the gender distribution in the groups. The mean albumin value in Group HA was statistically significantly lower than Group NHA (p=0.0001). Conclusion: In conclusion, EHA administration in hypoalbuminemic patients prolong stay in ICU in addition to the increase in the development of AKI and mortality.